Literature DB >> 6292299

Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction.

J J Wirth, F Kierszenbaum.   

Abstract

The effects of agents that elevate intracellular levels of cyclic AMP on the in vitro interaction of mouse peritoneal macrophages with virulent bloodstream forms of a reticulotropic strain of Trypanosoma cruzi were investigated as a part of our efforts to define the requirements for tissue invasion by this intracellular human pathogen. At optimal, non-toxic concentrations, both L-isoproterenol and prostaglandin E1, agents that increase cyclic AMP levels by activating adenylate cyclase via different mechanisms, reduced the uptake by T. cruzi by the macrophages by approximately 30 and 70%, respectively, and also caused a reduction in the numbers of macrophages capable of incorporating the parasites. Similar results were obtained when either theophylline, which increases cyclic AMP levels by inhibiting the catabolic effect of phosphodiesterase activity, was incorporated into the cultures or by direct addition of dibutyryl cyclic AMP. Reductions produced with optimal concentrations of these drugs amounted to approximately 40 to 50%. The present results indicate that binding and uptake of virulent forms of a reticulotropic strain of T. cruzi by macrophages from a susceptible host are under the regulatory influence of cellular cyclic AMP levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292299

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity.

Authors:  María Noel Alvarez; Gonzalo Peluffo; Lucía Piacenza; Rafael Radi
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

2.  Impairment of macrophage function by inhibitors of ornithine decarboxylase activity.

Authors:  F Kierszenbaum; J J Wirth; P P McCann; A Sjoerdsma
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

3.  Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.

Authors:  R L Friedman; R L Fiederlein; L Glasser; J N Galgiani
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Characterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. leprae.

Authors:  Avinash R Shenoy; Nandini P Sreenath; Mohana Mahalingam; Sandhya S Visweswariah
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

5.  Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins.

Authors:  Andre Talvani; Sibele Ferreira Coutinho; Luciola da Silva Barcelos; Mauro Martins Teixeira
Journal:  Parasitol Res       Date:  2008-12-18       Impact factor: 2.289

6.  Macrophage activation by cord factor (trehalose 6,6'-dimycolate): enhanced association with and intracellular killing of Trypanosoma cruzi.

Authors:  F Kierszenbaum; A Zenian; J J Wirth
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

7.  The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.

Authors:  N C Turner; L J Wood; F M Burns; T Gueremy; J E Souness
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Cytosolic-free calcium elevation in Trypanosoma cruzi is required for cell invasion.

Authors:  S N Moreno; J Silva; A E Vercesi; R Docampo
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

9.  A survey of nucleotide cyclases in actinobacteria: unique domain organization and expansion of the class III cyclase family in Mycobacterium tuberculosis.

Authors:  Avinash R Shenoy; K Sivakumar; A Krupa; N Srinivasan; Sandhya S Visweswariah
Journal:  Comp Funct Genomics       Date:  2004
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.